ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026
F-wave vector magnitude predicts recurrence after catheter ablation of atrial fibrillation.
Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCatheter ablation for atrial fibrillation (AF) carries a known risk of tachyarrhythmia recurrence, but the recurrence is still difficult to predict before the procedure. This study assessed the value of noninvasive f-wave vector magnitude (FVM) during AF in predicting recurrence following ablation.
methodsThis observational study included 604 consecutive patients who underwent initial AF ablation between January 2017 and December 2022 at Mitsubishi Kyoto Hospital, and whose baseline 12-lead electrocardiograms during AF were available. The maximal f-wave amplitude (FWA) over a 10-s period was measured manually using computerized calipers, and FVM was defined as the magnitude of atrial depolarization in three-dimensional space, calculated using the visually transformed Kors' quasi-orthogonal method. The outcome measure was the recurrence of atrial tachyarrhythmias after a 90-day post-procedural blanking period.
resultsThe median follow-up was 5.4 (3.9-7.1) years. In multivariable analysis, low FVM (< 0.18 mV) was an independent predictor of recurrence (hazard ratio [HR] = 1.56, 95% confidence interval [CI] = 1.16-2.15, p < 0.01) as well as left atrial dilatation (≥ 45 mm) (HR = 1.46, 95% CI = 1.08-1.98, p = 0.01). The 5-year recurrence-free rate after initial ablation was lowest in patients with both low FVM and left atrial dilatation (53.9%), and highest in those with neither (78.3%, p < 0.001). The risk stratification was only clear in patients with non-paroxysmal AF (49.4% vs. 79.9%, p < 0.001). In contrast, FWA below 0.10 mV in lead V1, defined as a fine f-wave, was not associated with recurrence following ablation.
conclusionsNoninvasive FVM measurement stratified the risk of recurrence after AF ablation in patients with non-paroxysmal AF, but did not show predictive value in those with paroxysmal AF.
Indexed as
Identifiers
42568004What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.